Related by context. All words. (Click for frequent words.) 66 Vaxfectin 65 MVA BN ® 64 peptide antigens 63 Vaxfectin adjuvant 63 LEAPS TM 63 chlamydial 62 antigen sparing 62 Vaxfectin R 62 Vaxfectin R adjuvant 62 SynCon 62 Vaxfectin ® 62 Intradermal 61 Vaxfectin TM 61 pDNA vaccines 61 intradermal delivery 61 metabolomic profiling 61 microneedle 61 nasal powder 61 adeno associated viruses 61 transcutaneous immunization TCI 61 valent pneumococcal conjugate vaccine 61 protein antigens 61 DermaVir 61 SynCon TM 61 poliovirus vaccine 61 DepoVax TM 61 trivalent inactivated influenza 61 GeoVax HIV AIDS 61 RECALL VAX TM 61 live attenuated intranasal 61 GeoVax vaccine 60 TriGrid 60 Nanopatch 60 reverse vaccinology 60 inactivated flu 60 ChronVac C 60 humoral responses 60 Vaxfectin TM adjuvant 60 adenoviral vectors 60 monovalent vaccine 60 AdVac ® 60 lentiviral 60 Novavax VLP vaccine 60 GelVac TM 60 live attenuated vaccines 60 SynCon ™ DNA 60 TransVax tm 60 GRNVAC1 60 lentiviral vectors 60 BioVant 60 radezolid 60 DNA plasmids 60 TLR agonists 60 adjuvants substances 60 vaginal microbicide gel 60 humanized monoclonal antibodies 59 recombinant hepatitis B 59 Microneedles 59 Microneedle 59 antisense compounds 59 fusion enhancers 59 virosome 59 CMV vaccine 59 immunized mice 59 intradermally 59 TransVax ™ 59 AFFITOME R 59 DiLA2 59 LC#m# 59 pharmacogenetic testing 59 immunological responses 59 PROCHYMAL 59 Cytolin R 59 inactivated viruses 59 poorly immunogenic 59 FLU v 59 Zalypsis 59 ROTARIX 59 SynCon ™ 59 Iomai vaccine 59 adenovirus vector 58 Thiovir 58 immunostimulants 58 xTAG RVP 58 antigenicity 58 pharmacodynamic markers 58 DepoVax ™ 58 anti idiotype 58 concomitantly administered 58 Nanobodies ® 58 toxoids 58 virus HBV 58 live attenuated influenza 58 virosomes 58 immunogens 58 Apatone 58 polysaccharide vaccines 58 proprietary VLP 58 CCR5 receptor antagonist 58 reactogenicity 58 VIRUSMAX TM 58 Nucleic acid 58 PREVENAR 58 influenza VLP vaccine 58 chimpanzee adenovirus 58 NNRTI resistant virus 58 Rimantadine 58 Multimeric 58 intranasal mist 58 Neugene 58 MVA BN R 58 Biojector ® 58 non adjuvanted vaccine 58 intradermal injection 58 microneedle patch 58 Vaxfectin TM formulated 58 ImmunoVEX 58 nutrient supplementation 58 multivalent vaccine 57 multidose 57 Bacille Calmette Guerin BCG 57 microRNA biomarkers 57 nanoviricides 57 HIB vaccine 57 molecularly targeted therapies 57 chickenpox varicella 57 intranasal delivery 57 trivalent seasonal influenza 57 Plasmid DNA 57 hPTH #-# 57 Vaxfectin R formulated 57 viral isolates 57 busulfan 57 VersaFilm 57 Inovio electroporation 57 idiotype vaccines 57 nanoviricide 57 SynCon TM DNA 57 ADME properties 57 postexposure prophylaxis 57 recombinant influenza 57 NovaBay Aganocide compounds 57 CCR5 inhibitor 57 ChronVac C R 57 eppin 57 inactivated influenza 57 Vacc 4x 57 NexACT ® 57 fluorescent pigments 57 postexposure 57 environmental toxicants 57 FluChip 57 microinjection 57 topical retinoids 57 NEUGENE 57 Cerashield ™ 57 nasally delivered 57 transdermal gel 57 non adjuvanted vaccines 57 AAV vectors 57 ImmunoVEX HSV2 57 HuCAL antibodies 57 adjuvanted vaccines 57 nanocarrier 57 ChimeriVax JE 57 LLLT 57 nasal spray influenza 57 investigational integrase inhibitor 57 helminth 57 alum adjuvanted 57 PCV1 57 oral PrEP 57 GelSite polymer 57 transgenic rats 57 HBV vaccine 57 recombinant interferon 57 immunotherapeutic approaches 57 oral poliovirus 57 tigecycline 57 FluCide ™ 57 induces antibodies 57 immunostimulant 57 CCR5 inhibitors 57 azelaic acid 57 viral antigen 56 Gardasil human papillomavirus 56 MenACWY 56 Inovio proprietary electroporation 56 serum antibody 56 hepatitis B immune globulin 56 plasmid DNA pDNA 56 toxoid 56 VivaGel TM 56 inactivated vaccines 56 salmon calcitonin 56 spermicide nonoxynol 9 56 anti microbials 56 MeNZB ™ 56 novel peptide 56 OMP #M# 56 Tamiflu Relenza 56 topical microbicides 56 recombinant antibodies 56 Balloon sinuplasty 56 Protein Expression 56 Humenza 56 glycan microarray 56 IgG1 antibodies 56 metabonomics 56 AZT 3TC 56 Respiratory Syncytial Virus RSV 56 Varicella chicken pox 56 Cytori Celution System 56 TransVax 56 microneedle patches 56 PHY# [002] 56 FluINsure 56 inhalable vaccine 56 DermaVir Patch 56 chemopreventive agents 56 preclinically 56 Dr. Gambotto 56 Nanoemulsion 56 CYT# NicQb 56 Dyax phage display 56 Fluzone Intradermal vaccine 56 NITD# 56 adenovirus serotype 56 rxRNA ™ compounds 56 vaccine Zostavax 56 biodegradable nanoparticles 56 injectible vaccine 56 meningococcal serogroup B 56 NanoCrystal Technology 56 vivo potency 56 HIV protease inhibitors 56 HTS assay 56 tumor specific antigen 56 Nestorone 56 virologic responses 56 autoimmune cardiovascular 56 Bacille Calmette Guérin BCG 56 Sinovac vaccine 56 ALK inhibitors 56 eTag assays 56 prevent reinfection 56 P. vivax malaria 56 herpes zoster vaccine 56 protease inhibitors PIs 56 cytomegalovirus retinitis 56 conjugate vaccines 56 nattokinase 56 Invirase saquinavir 56 Climara Pro 56 Nelfinavir 56 inactivated vaccine 56 dose intramuscular 56 Anticalins ® 56 antitumour 56 Pre Exposure Prophylaxis 56 BioSilicon 56 secretin 56 Modified Vaccinia Ankara MVA 56 #T# L1 56 cellular immunotherapy 56 preclinical efficacy 56 IgG isotype 56 beta lactam antibiotic 56 Panenza 56 DermaPrep 56 flavopiridol 56 attenuated weakened 56 Nasal spray flu 56 nonviral 55 ESBA# 55 intranasal influenza 55 GelVac ™ 55 superspreaders 55 anti CD# antibodies 55 gp# vaccine 55 LNP formulations 55 Human cl 55 hypoxic tumors 55 Cyclosert TM 55 Hedgehog inhibitor 55 tetravalent vaccine 55 telomerase activator 55 Streptomyces bacteria 55 Tekmira SNALP technology 55 autism spectrum diagnoses 55 intra dermal 55 GelVac 55 serogroup B 55 Adjuvanted 55 Pentacel vaccine 55 predictive biomarkers 55 immunosuppressive regimens 55 prepandemic 55 cidofovir 55 ToleroMune 55 serologic testing 55 Smallpox vaccine 55 Latex condoms 55 VLP vaccine candidate 55 aerosolized surfactant 55 intradermal 55 RiVax 55 transdermally 55 immunomodulators 55 TransVax TM 55 convenient dosing regimens 55 DNAwithPap TM Test 55 DepoVax 55 peptides proteins 55 VAX# 55 HCV protease inhibitors 55 IgM antibodies 55 SIV infection 55 DepoVax ™ vaccine 55 lyophilized formulation 55 H#N# VLP vaccine 55 Twinrix 55 nevirapine regimen 55 potent recombinant 55 biologically degradable 55 Sanofi Pasteur ALVAC canary 55 Zysolin TM 55 Bacillus Calmette Guerin BCG 55 inactivated strain 55 genomic biomarkers 55 CD8 T cell 55 TriGrid ™ 55 HepaGam B 55 stent coating 55 proprietary PEGylation 55 Electroporation 55 4CMenB 55 PROSTVAC TM 55 BARACLUDE R 55 DENVax 55 tetanus toxoid 55 staphylococcal vaccine 55 LAB CGRP 55 MVA#A 55 therapeutic monoclonal antibody 55 Mark Prausnitz 55 recombinant vaccines 55 phage display 55 LC#m# vaccine 55 Referenced EEG ® 55 abzymes 55 biotherapeutic drugs 55 TRIM5a 55 vaginal microbicides 55 neuro developmental disorders 55 microneedles 55 virus AAV 55 Streptococcus pneumonia 55 therapeutic monoclonal antibodies 55 Cyclosert 55 Hemopurifier 55 seasonal influenza strains 55 SPRIX ® 55 Helicobacter pylori H. pylori 55 biotherapy 55 Iomai patch 55 replicon 55 Sasisekharan 55 antibody reagents 55 therapeutic regimens 55 acyclovir valacyclovir 55 nucleotide analogue 55 CobaCyte 55 attenuated vaccine 55 containing abacavir 55 Cytolin ® 55 lipid nanoparticles 55 viral kinetics 55 PCV# 55 varicella zoster virus VZV 55 inhibit metastasis 55 intradermal vaccine 55 PPSV# 55 Qlaira 55 noscapine 55 nanoprobe 55 chlamydia trachomatis 55 optical biosensors 55 OncoVEX 55 antitumor effect 55 biostatistical analysis 55 inactivated poliovirus 55 HEPLISAV TM hepatitis B 55 Spiriva HandiHaler 55 Radilex 55 FTIs 54 pharmacodynamic parameters 54 avian H#N# 54 leukocyte reduction 54 MenACWY CRM 54 dose proportionality 54 DCVax R 54 streptococcal vaccine 54 MiStent DES 54 Cerashield 54 Fikrig 54 Mymetics vaccine 54 pox vaccine 54 pneumococcal conjugate 54 Sanofi Lovenox 54 Aethlon Hemopurifier R 54 transfection efficiency 54 VLPs 54 CDDO Im 54 inactivated influenza vaccine 54 MF# adjuvant 54 HPV Human Papillomavirus 54 Vetericyn ™ 54 vivo electroporation 54 VIR# 54 HPV genotyping 54 A/H#N# pandemic influenza 54 GRFT 54 intra nasal 54 using Crucell PER.C6 54 PET tracers 54 lipid particles 54 antiangiogenic drugs 54 intranasal influenza vaccine 54 ELISpot 54 quadrivalent vaccine 54 Colloidal silver 54 biomolecular interactions 54 dispersible tablet 54 telomerase activation 54 vaccinology 54 Bioniche E. coli 54 pre exposure prophylaxis 54 subunit vaccine 54 Apobec3 54 Rigorous scientific 54 highly immunogenic 54 enterotypes 54 contain thimerosal 54 rxRNA TM compounds 54 BioMAP 54 simian immunodeficiency virus 54 Cardiotoxicity 54 virology immunology 54 recombinant spider silk 54 bioabsorbable polymer 54 vitamin D analogs 54 Aethlon Hemopurifier 54 discodermolide 54 PORxin TM 54 blockers angiogenesis inhibitors 54 parthenogenetic embryonic stem cells 54 Raltegravir 54 Intercell Japanese Encephalitis 54 delipidation 54 HBsAg 54 bioinformatic approaches 54 AAV vector 54 ImmuKnow 54 #I TM# 54 developmental neurotoxicity 54 Chickenpox vaccine 54 investigational hepatitis B 54 PCR primers 54 conserved antigens NP 54 measles mumps rubella varicella 54 antiviral efficacy 54 HCV replicon 54 eligen 54 viral proteins 54 PEGylated interferon 54 insertional mutagenesis 54 co trimoxazole 54 Pertuzumab 54 NYSE Amex SVA 54 Melanotan II 54 BEXXAR Therapeutic Regimen 54 Sustiva efavirenz 54 liposomal formulations 54 #beta estradiol 54 highly pathogenic influenza 54 nifurtimox 54 baculovirus 54 Baxter Celvapan 54 CCR5 mAb 54 allogeneic HSCT 54 monoclonal antibody therapies 54 CAM modalities 54 mda 7 54 KINRIX 54 ESBL producing E. coli 54 Nucleic acids 54 toxicogenomic 54 fumagillin nanoparticles 54 antiplatelet therapies 54 Insect repellents 54 Merck RotaTeq 54 lipid nanoparticle 54 Hemopurifier TM 54 potent cytotoxic 54 CERVARIX 54 influenza VLP vaccines 54 transdermal insulin 54 synDNA TM 54 NEUGENE antisense 54 cMET 54 shingles vaccine Zostavax 54 psychopharmacological 54 adipose derived stem cells 54 ddRNAi 54 Sentinel Lymph Node Biopsy 54 Foradil Aerolizer 54 Tumor Response 54 cediranib 54 SparVax ™ 54 Fleximer R 54 immunotoxins 54 avian strain 54 proteomic technologies 54 Crixivan 54 PCV7 vaccine 54 modified vaccinia Ankara 54 lipidoid 54 Flow cytometry 54 Havrix 54 Kawaoka explains 54 immunologic responses 54 BACcel 54 telomerase inhibitor 54 purified inactivated vaccine 54 viral vectors 54 Alequel ™ 54 Captisol Enabled 54 CRLX# 54 Dryvax vaccine 54 bepotastine besilate 54 h#n# vaccine 54 Nasal spray 54 bacterium Listeria 54 M2e 54 cotrimoxazole 54 immune globulins 53 sipuleucel T 53 hMPV 53 proprietary electroporation 53 siRNA knockdown 53 immunotherapeutic vaccine 53 synthetic progesterone 53 Hib vaccines 53 immuno therapeutic 53 Mathematical modeling 53 Merck Suspends Lobbying 53 recombinant adeno associated 53 trivalent seasonal flu 53 Elvitegravir 53 MVA nef 53 Monoclonal antibody 53 antifungal medications 53 methylation markers 53 attenuated strain 53 RECALL VAX 53 Synchrony lens 53 oligonucleotide microarrays 53 vero cell 53 inhibit viral replication 53 aldose reductase inhibitors 53 intensive lipid lowering 53 trivalent influenza vaccine 53 OncoVex 53 Vascugel ® 53 RGD peptides 53 insecticidal properties 53 selenium supplementation 53 ONCONASE R 53 parenterally administered 53 mAbs 53 Intravenous immunoglobulin 53 HepaMate 53 inecalcitol 53 polyclonal 53 tipranavir 53 oral rotavirus vaccine 53 Flu Mist nasal spray 53 phosphorylcholine 53 vitro maturation IVM 53 tetanus diphtheria vaccine 53 Western Blotting 53 Aethlon Hemopurifier ® 53 transgene expression 53 perfusion MRI 53 penicillin amoxicillin 53 2D electrophoresis 53 therapeutically useful 53 biomarker identification 53 topical NSAIDs 53 inactivated influenza virus 53 monoclonals 53 ELISPOT assay 53 hepatitis B immunization 53 BLP# 53 Valortim R 53 Pandemic Influenza Vaccine 53 Insect repellants 53 Vaginal gel 53 dapsone 53 ImmuKnow R 53 D 1mT 53 quinacrine 53 recombinant vaccine 53 genomic microarray 53 transfection reagents 53 M. paratuberculosis 53 AKT1 mutation 53 moxidectin 53 DNA methylation markers 53 Capsulution 53 rhLF 53 Immunotherapeutic 53 Temsirolimus 53 Nasal Powder 53 Crucell genetically engineered 53 pharmacokinetic characteristics 53 Adhibit 53 Sphingomab 53 injectable antibiotics 53 Bacille Calmette Guerin 53 Randomized clinical trials 53 easypod 53 Non inferiority 53 Antioxidant supplements 53 careHPV 53 Inovio proprietary 53 Illumina Solexa 53 VLP influenza 53 zinc nasal gel 53 antiangiogenesis 53 Inactivated 53 telomere biology 53 protein biomarker discovery 53 pharmacodynamic properties 53 immunological mechanisms 53 Anticalins R 53 highly pathogenic viruses 53 vaccine adjuvants 53 Tamiflu oseltamivir 53 pleiotropic effects 53 Smallpox vaccines 53 HSP# inhibitors 53 vidofludimus 53 cervical precancerous lesions 53 co receptor tropism 53 CyPath ® 53 rhITF 53 empiric therapy 53 valganciclovir 53 exendin 4 53 protein electrophoresis 53 ACTCellerate 53 biomarker discovery validation 53 siRNA transfection 53 acellular pertussis DTaP 53 calcitonin 53 TWYNSTA 53 immune suppressing medications 53 fungal genomes 53 antiviral compounds 53 antitumor efficacy 53 Vaxart 53 Altrazeal R 53 plasma pharmacokinetics 53 transfusion transmitted 53 HIV coinfected 53 recombinant vector 53 pharmacokinetic interactions 53 DNA methylation biomarkers 53 meropenem 53 Inovio DNA 53 rxRNA compounds 53 Labguard TM 53 steroid dexamethasone 53 Novavax VLP 53 molecular biomarkers 53 Umbilical cord stem cells 53 allergen avoidance 53 molecular imprinting 53 anti angiogenic drugs 53 pandemic influenza strains 53 myoblast therapy 53 PCR Polymerase Chain Reaction 53 virological suppression 53 pharmacogenetic tests 53 small molecule PEGylation 53 TriMix gel TM 53 EpiVax 53 DSSCs 53 gynaecologic 53 DEEP AF 53 thimerosol 53 ANAVEX #-# [001] 53 intradermal injections 53 metastatic neuroendocrine tumors 53 HCV replication 53 diphtheria pertussis whooping cough 53 dermatologic diseases 53 CELVAPAN H#N# 53 adjuvanted H#N# 53 immune modulatory 53 H#N# antigen 53 micronutrient supplements 53 multiplex immunoassays 53 hemagglutination inhibition HAI 53 Nexavar sorafenib tablets 53 near infrared spectroscopic 53 Antiviral drugs 53 forensicGEM TM 53 transgenic mosquito 53 monolaurin 53 malaria endemic regions 53 RONDEL ™ 53 Lovaxin C 53 Pediarix 53 candidate TNFerade biologic 53 parainfluenza virus 53 transgenesis 53 Ligand Epitope Antigen Presentation 53 kidney urologic 53 oral rinse 53 DCVax ® 53 zinc supplementation 53 microcapsule 53 proteins peptides 53 biotherapies 53 Capsule endoscopy 53 Arranon 53 antibiotics ciprofloxacin 53 intravenous IV iron 53 siRNAs targeting 53 diptheria tetanus 53 GVAX ® 53 Inhaled nitric oxide 53 trastuzumab DM1 T DM1 53 HuMax HepC 53 administered intranasally 53 Valtrex valacyclovir 53 MaxCyte STX 53 LungSign TM 53 radiolabeled TM# 53 ChronVac C ® 53 diphtheria toxoids 52 PENNVAX ™ B 52 Chemetics R 52 Systematic reviews 52 Phage Pharmaceuticals 52 influenza subtype 52 RDTs 52 nCounter 52 lipid nanoparticles LNPs 52 molecular determinants 52 Flexible sigmoidoscopy 52 GelSite R polymer 52 immunostimulant patch 52 sputum specimens 52 Sanofi Pasteur Fluzone 52 DAS# [001] 52 varicella chickenpox 52 Dynavax proprietary 52 biologic DMARDs 52 GlaxoSmithKline Rotarix 52 administered intramuscularly 52 Intranasal 52 GARDASIL ® 52 embryo clones 52 Photodynamic therapy PDT 52 intravenous catheters 52 Rotateq vaccine 52 Nektar proprietary 52 beta lactams 52 antihormonal 52 Japanese Encephalitis vaccine 52 valent pneumococcal 52 reagent kits 52 AERx ® 52 MF# adjuvanted 52 Locked Nucleic Acid LNA 52 therapies ACTs 52 Cerenia 52 dendritic cell vaccine 52 Anidulafungin 52 KRAS status 52 bOPV 52 Intravail R 52 MAGE A3 ASCI 52 HDL Selective Delipidation 52 sirtuin activators 52 OncoVEX GM CSF 52 genomic proteomic 52 pharmacokinetic equivalence 52 Polyzene R F 52 inactivated influenza vaccines 52 macrolide antibiotic 52 BioSET 52 HPV cervical cancer 52 bioactive molecules 52 diagnostics therapeutics 52 trivalent flu 52 stable nucleic acid 52 Comvax 52 zoster vaccine 52 fully liquid pentavalent 52 needleless 52 vaccine Fluarix 52 daptomycin 52 rPA 52 nasal spray vaccines 52 platypus venom 52 neuropsychiatric diseases 52 pathogenic mechanisms 52 Corus CAD 52 bioengineered tissue 52 emulsion formulations 52 vivo preclinical 52 carotid stents 52 viral tropism 52 quadrivalent human papillomavirus 52 Genentech Herceptin 52 genomic profiling 52 bioequivalency 52 severely immunosuppressed 52 soft gelatin capsule 52 menadione 52 multimodality imaging 52 inhibit replication 52 bovine mastitis 52 rifabutin 52 applied vaginally 52 dosimetric 52 serum biomarkers 52 PCV2 52 BeneFIX 52 polymer scaffold 52 monoclonal antibody MAb 52 artemisinin derivatives 52 near infrared fluorescence 52 Alternans 52 Micromet BiTE 52 hawthorn extract 52 stated Avtar Dhillon 52 adenovirus serotype 5 52 siRNA therapeutic 52 Interferon beta 52 FMD vaccines 52 pDNA vaccine 52 subcutaneous immunoglobulin 52 conjugate pneumococcal vaccine 52 botanically derived 52 rxRNA 52 spokeswoman Christine Fanelle 52 HLA DQ 52 nonsquamous 52 antibiotic streptomycin 52 acyclovir Zovirax 52 VZV 52 snake venoms 52 pertussis vaccines 52 hypericin 52 darunavir r 52 NicVAX vaccine 52 pramlintide metreleptin combination 52 CYT# potent vascular disrupting 52 sd rxRNA 52 demonstrated antitumor activity 52 S/GSK# 52 H5 avian 52 ValiMed System 52 conjugate vaccine 52 p# biomarker 52 microdose 52 immunotherapeutics 52 Enhanze Technology 52 transfection reagent 52 Onconase 52 adjuvant AS# 52 FluCide 52 PEG SN# 52 Virological 52 H#N# monovalent vaccine 52 psoralen 52 synthetic retinoid 52 immune suppressants 52 bivalent vaccine 52 RapidMist 52 nasally administered 52 mice ferrets 52 Aidsvax 52 tetanus pertussis 52 Universal Flu Vaccine 52 glial tumors 52 vaccine Menactra 52 nonpharmaceutical interventions 52 PET radiopharmaceuticals 52 VerifyNow System 52 polymer scaffolds 52 vaccine RotaTeq 52 antisera 52 ETEC vaccine 52 AlloMap testing 52 valacyclovir Valtrex 52 Tarvacin 52 Sialic Switch technology 52 GelVac TM powder 52 Tamiflu oseltamivir phosphate 52 protein microarrays 52 zero valent iron 52 multitargeted 52 Glide SDI 52 SNALP technology 52 intranasal vaccine 52 systemic siRNA 52 Sanofi Pasteur Menactra 52 Rotavirus vaccine 52 vitro dissolution 52 teriflunomide 52 EmbraceAC 52 riociguat 52 pneumococci 52 Asclera 52 BHT DNA 52 Motavizumab 52 plasmid DNA encoding 52 GIPET 52 Molluscum 52 neutralizing antibody titers 52 Bacillus Calmette Guerin 52 topical microbicide 52 MMP inhibitors 52 metabolite profiling 52 Azedra 52 inhaling nitric oxide 52 palivizumab 52 im peramivir 52 M2 inhibitors 52 non nucleoside HCV 52 capillary electrophoresis CE 52 Xenopus embryos 52 Balloon Sinuplasty TM 52 OROS ® 52 BioSilicon TM 52 ergot alkaloids 52 L lysine 52 Transcranial Magnetic Stimulation TMS 52 oral antiviral 52 allergen immunotherapy 52 Gambotto 52 TLR9 agonist 52 ENMD # 52 Tem PCR 52 HEPLISAV TM 52 effector functions 52 Alferon N 52 topical diclofenac 52 racemate 52 trastuzumab Herceptin 52 Afluria 52 FLUARIX 52 SparVax 52 antitumoral 52 Tuberculosis Vaccine 52 severely immunocompromised patients 52 bacterial contaminations 52 Potelligent Technology 52 biologic therapeutics 52 XTEN 52 novel immunotherapeutic 52 RXi sd rxRNA compounds 52 thiomersal 52 nanoneedle 52 clevidipine 52 Protease inhibitor 52 seasonal influenza vaccines 52 AQUA ® 52 prognostic markers 52 sterile syringe 52 nanoparticle formulations 52 unadjuvanted vaccines 52 physicochemical properties 52 catalytic antibodies 52 magnetic resonance spectroscopy MRS 52 Coartem Dispersible 52 Vascugel R 52 gamma globulin 52 MF# adjuvanted vaccine 52 intestinal mucosal 52 influenza antiviral medications 52 Gamunex C